Stanozolol

Jump to: navigation, search
Stanozolol
File:Stanozolol.svg
Clinical data
Pregnancy
category
  • X
Routes of
administration
Oral, Intramuscular
ATC code
Legal status
Legal status
  • Prescription only
    (US)
Pharmacokinetic data
Bioavailability?
MetabolismHepatic
Elimination half-life1 day
ExcretionRenal: 84%
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC21H32N2O
Molar mass328.49

WikiDoc Resources for Stanozolol

Articles

Most recent articles on Stanozolol

Most cited articles on Stanozolol

Review articles on Stanozolol

Articles on Stanozolol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Stanozolol

Images of Stanozolol

Photos of Stanozolol

Podcasts & MP3s on Stanozolol

Videos on Stanozolol

Evidence Based Medicine

Cochrane Collaboration on Stanozolol

Bandolier on Stanozolol

TRIP on Stanozolol

Clinical Trials

Ongoing Trials on Stanozolol at Clinical Trials.gov

Trial results on Stanozolol

Clinical Trials on Stanozolol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Stanozolol

NICE Guidance on Stanozolol

NHS PRODIGY Guidance

FDA on Stanozolol

CDC on Stanozolol

Books

Books on Stanozolol

News

Stanozolol in the news

Be alerted to news on Stanozolol

News trends on Stanozolol

Commentary

Blogs on Stanozolol

Definitions

Definitions of Stanozolol

Patient Resources / Community

Patient resources on Stanozolol

Discussion groups on Stanozolol

Patient Handouts on Stanozolol

Directions to Hospitals Treating Stanozolol

Risk calculators and risk factors for Stanozolol

Healthcare Provider Resources

Symptoms of Stanozolol

Causes & Risk Factors for Stanozolol

Diagnostic studies for Stanozolol

Treatment of Stanozolol

Continuing Medical Education (CME)

CME Programs on Stanozolol

International

Stanozolol en Espanol

Stanozolol en Francais

Business

Stanozolol in the Marketplace

Patents on Stanozolol

Experimental / Informatics

List of terms related to Stanozolol


Overview

Stanozolol, commonly sold under the name Winstrol (oral) and Winstrol Depot (intra-muscular), was developed by Winthrop Laboratories in 1962. It is a synthetic anabolic steroid derived from testosterone, and has been approved by the FDA for human use.

Unlike most injectable anabolic steroids, Stanozolol is not esterified and is sold as an aqueous suspension, or in oral tablet form. The drug has a large oral bioavailability, due to a C17 α-alkylation which allows the hormone to survive first pass liver metabolism when ingested. It is because of this that Stanozolol is also sold in tablet form.

Stanozolol is usually considered a safer choice for female bodybuilders in that it rewards a great amount of anabolism for a small androgenic effect, however virilization and masculinization are still very common, even at low doses.

Stanozolol has been used on both animal and human patients for a number of conditions. In humans, it has been demonstrated to be successful in treating anaemia and hereditary angioedema. Veterinarians may prescribe the drug to improve muscle growth, red blood cell production, increase bone density and stimulate the appetite of debilitated or weakened animals.

Stanozolol is one of the Anabolic steroids commonly used as an ergogenic aid and is banned from use in sports competition under the auspices of the International Association of Athletics Federations (IAAF).

References




Linked-in.jpg